These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 7957541

  • 1. Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine.
    Hagen E, Istad H, Ose L, Bodd E, Eriksen HM, Selvig V, Bard JM, Fruchart JC, Borge M, Wolf MC.
    Eur J Clin Pharmacol; 1994; 46(5):445-9. PubMed ID: 7957541
    [Abstract] [Full Text] [Related]

  • 2. Long-term efficacy with fluvastatin as monotherapy and combined with cholestyramine (a 156-week multicenter study). French-Dutch Fluvastatin Study Group.
    Jacotot B, Banga JD, Waite R, Peters TK.
    Am J Cardiol; 1995 Jul 13; 76(2):41A-46A. PubMed ID: 7604796
    [Abstract] [Full Text] [Related]

  • 3. Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.
    Sprecher DL, Abrams J, Allen JW, Keane WF, Chrysant SG, Ginsberg H, Fischer JJ, Johnson BF, Theroux P, Jokubaitis L.
    Ann Intern Med; 1994 Apr 01; 120(7):537-43. PubMed ID: 8093139
    [Abstract] [Full Text] [Related]

  • 4. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1996 Jan 01; 77A():28-32. PubMed ID: 8729588
    [Abstract] [Full Text] [Related]

  • 5. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec 01; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

  • 6. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
    Bard JM, Ose L, Hagen E, Duriez P, Pfister P, Fruchart JC, Dallongeville J.
    Am J Cardiol; 1995 Jul 13; 76(2):65A-70A. PubMed ID: 7604802
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination.
    Leitersdorf E, Muratti EN, Eliav O, Meiner V, Eisenberg S, Dann EJ, Sehayek E, Peters TK, Stein Y.
    Am J Med; 1994 May 13; 96(5):401-7. PubMed ID: 8192170
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia.
    Leitersdorf E, Muratti EN, Eliav O, Peters TK.
    Am J Cardiol; 1995 Jul 13; 76(2):84A-88A. PubMed ID: 7604807
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial.
    Zavoral JH, Haggerty BJ, Winick AG, Bergmann SD.
    Am J Cardiol; 1995 Jul 13; 76(2):37A-40A. PubMed ID: 7604795
    [Abstract] [Full Text] [Related]

  • 10. Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrate.
    Greten H, Beil FU, Schneider J, Weisweiler P, Armstrong VW, Keller C, Klör HU, von Hodenberg E, Weidinger G, Eskötter H.
    Am J Med; 1994 Jun 06; 96(6A):55S-63S. PubMed ID: 8017468
    [Abstract] [Full Text] [Related]

  • 11. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
    Sasaki J, Yamamoto K, Kobori S, Setoguchi Y, Sato Y, Matsunaga A, Shichiri M, Sakai T, Kono S, Arakawa K.
    Int J Clin Pharmacol Ther; 1995 Jul 06; 33(7):420-6. PubMed ID: 7582401
    [Abstract] [Full Text] [Related]

  • 12. High-dose fluvastatin and bezafibrate combination treatment for heterozygous familial hypercholesterolemia.
    Eliav O, Schurr D, Pfister P, Friedlander Y, Leitersdorf E.
    Am J Cardiol; 1995 Jul 13; 76(2):76A-79A. PubMed ID: 7604804
    [Abstract] [Full Text] [Related]

  • 13. Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia.
    Isaacsohn JL, LaSalle J, Chao G, Gonasun L.
    Clin Ther; 2003 Mar 13; 25(3):904-18. PubMed ID: 12852707
    [Abstract] [Full Text] [Related]

  • 14. Fluvastatin in primary hypercholesterolemia: efficacy and safety in patients at high risk. An analysis of a clinical trial database.
    Peters TK, Muratti EN, Mehra M.
    Am J Med; 1994 Jun 06; 96(6A):79S-83S. PubMed ID: 8017471
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.
    Ballantyne CM, Pazzucconi F, Pintó X, Reckless JP, Stein E, McKenney J, Bortolini M, Chiang YT.
    Clin Ther; 2001 Feb 06; 23(2):177-92. PubMed ID: 11293552
    [Abstract] [Full Text] [Related]

  • 16. Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database.
    Peters TK.
    Am J Cardiol; 1995 Jul 13; 76(2):71A-75A. PubMed ID: 7604803
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P.
    Am J Cardiovasc Drugs; 2006 Jul 13; 6(3):177-88. PubMed ID: 16780391
    [Abstract] [Full Text] [Related]

  • 18. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group.
    Jacotot B, Benghozi R, Pfister P, Holmes D.
    Am J Cardiol; 1995 Jul 13; 76(2):54A-56A. PubMed ID: 7604799
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein composition.
    Bard JM, Dallongeville J, Hagen E, Pfister P, Ose L, Fruchart JC, Duriez P.
    Metabolism; 1995 Nov 13; 44(11):1447-54. PubMed ID: 7476333
    [Abstract] [Full Text] [Related]

  • 20. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.
    Goldberg RB, Roth D.
    Am J Cardiol; 1995 Jul 13; 76(2):107A-109A. PubMed ID: 7604782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.